Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Edesa Biotech Inc.

Clinicaltrial registered22 Oct 2026

Edesa Biotech Inc.

22 Oct 2026: Trial registered · A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
22 Oct 2026
Title
A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
Conditions
Non-Segmental Vitiligo (NSV)
Phase
Phase 2
Study Type
Interventional
Status
Recruiting
Countries
Canada, Panama
Country
Canada
Reference
NCT07889492
Location
Canada, Panama
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Edesa Biotech Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Canada

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.